Patients and their doctors should be able to make treatment decisions without involvement from the federal government, said Starlee Coleman, senior policy advisor for the Goldwater Institute, a libertarian think tank that lobbied successfully for widespread adoption of right-to-try laws.
An analysis by researchers from the International Agency for Research on Cancer casts doubt on validity of an endpoint used in key studies of multi-cancer detection tests.
